Loading…
The Cigna Group is projected to rise to $327.73 by 2027, a +15% move from its current price of $285.75. CI is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $281.53 | $285.79 | $290.10 | +0.01% |
| May 30 | $279.82 | $285.82 | $291.95 | +0.02% |
| May 31 | $278.53 | $285.86 | $293.38 | +0.04% |
| Jun 1 | $277.45 | $285.89 | $294.60 | +0.05% |
| Jun 2 | $276.50 | $285.93 | $295.68 | +0.06% |
| Jun 3 | $275.65 | $285.96 | $296.66 | +0.07% |
| Jun 4 | $274.88 | $286.00 | $297.57 | +0.09% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $274.88 | $286.00 | $297.57 | +0.09% |
| Week 2 | $270.63 | $286.25 | $302.77 | +0.18% |
| Week 3 | $267.48 | $286.50 | $306.88 | +0.26% |
| Week 4 | $264.88 | $286.75 | $310.43 | +0.35% |
| Week 5 | $262.64 | $287.00 | $313.62 | +0.44% |
| Week 6 | $260.65 | $287.25 | $316.57 | +0.53% |
| Week 7 | $258.86 | $287.50 | $319.32 | +0.61% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes.
The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses.
The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
The Cigna Group (CI) is a healthcare-focused insurer and services company in the United States, organized around two main segments: Evernorth Health Services and Cigna Healthcare. It trades at $286.24 per share and has a market cap of $75.72B, ranking 221 by market capitalization. The current price and market positioning place CI within a broad insurance and health services landscape.
The stock’s near-term technical picture shows a neutral-to-bullish setup with a defined 30-day range and clear support and resistance levels that frame its price trajectory.
A major floor 11.5% below — a decisive break under it would weaken the trend.
The nearest floor, 6.0% below — buyers have tended to step in here.
The nearest ceiling, 5.2% above — a clean break opens room to run.
A major ceiling 11.0% above — clearing it would confirm fresh momentum.
Key CI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $283.59 | Buy | $284.77 | Buy |
| MA 10 | $287.68 | Sell | $285.79 | Sell |
| MA 20 | $286.96 | Sell | $285.21 | Buy |
| MA 50 | $277.83 | Buy | $281.57 | Buy |
| MA 100 | $278.57 | Buy | $280.38 | Buy |
| MA 200 | $282.27 | Buy | $284.50 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 51.35 | Neutral |
| Stoch RSI (14) | 20.92 | Neutral |
| CCI (20) | -16.27 | Neutral |
| Williams %R (14) | -75.25 | Info |
| MACD (12,26,9) | -1.18 | Sell |
| ROC (12) | -0.80 | Sell |
| Bollinger %B (20,2) | 0.45 | Neutral |
| Stochastic %K (14) | 24.75 | Neutral |
| TRIX (15) | 0.16 | Buy |
| Awesome (5,34) | 0.81 | Buy |
| Ultimate (7,14,28) | 51.85 | Neutral |
| Momentum (10) | -12.74 | Sell |
| Aroon Osc (25) | 60.00 | Buy |
| Hull MA (9) | 282.15 | Buy |
| ADX (14) | 10.58 | Neutral |
| ATR (14) | 4.50 | Info |
The 30-day technical picture is bullish. RSI14 is 50, and the stock trades relative to the SMA50 at $277.21 and the SMA200 at $282.16. A near-term floor sits at $268.63 with resistance at $300.71, suggesting a measured path within a roughly $259.34 to $315.94 30-day range.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $258.08 | $285.75 | $370.27 | 0% | Neutral | |
| $267.73 | $327.73 | $419.92 | +15% | Neutral | |
| $276.73 | $344.92 | $453.50 | +21% | Bullish | |
| $302.11 | $382.26 | $513.05 | +34% | Bullish | |
| $343.98 | $441.04 | $602.41 | +54% | Bullish | |
| $398.45 | $517.05 | $717.24 | +81% | Bullish | |
| $440.09 | $577.49 | $812.33 | +102% | Bullish | |
| $452.46 | $599.92 | $854.70 | +110% | Bullish | |
| $483.81 | $647.83 | $933.88 | +127% | Bullish | |
| $507.18 | $685.51 | $999.12 | +140% | Bullish | |
| $745.09 | $1,050.20 | $1,603.56 | +268% | Bullish | |
| $1,392.42 | $2,104.53 | $3,443.58 | +636% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $258.08 | $285.75 | $333.54 | +0.00% |
| June 2026 | $242.61 | $283.02 | $336.56 | -0.96% |
| July 2026 | $246.34 | $289.02 | $346.95 | +2.12% |
| August 2026 | $247.65 | $291.88 | $352.93 | +0.99% |
| September 2026 | $244.22 | $288.89 | $351.40 | -1.02% |
| October 2026 | $246.69 | $292.81 | $358.08 | +1.36% |
| November 2026 | $252.72 | $300.87 | $369.67 | +2.75% |
| December 2026 | $251.29 | $300.02 | $370.27 | -0.28% |
Click any year to see its month-by-month CI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, CI is projected to trade between $258.08 and $370.27, averaging $285.75 — a potential gain of 0% from today's $285.75. A consolidation phase looks the most probable path here.
The Cigna Group's 2027 outlook centres on $327.73, within a $267.73 to $419.92 range. That is up +15% on the projected 2026 average. That marks a +15% change versus current levels. Price action looks broadly range-bound.
By 2028, CI could reach as high as $453.50, with a base case around $344.92 and support toward $276.73 — roughly +21% from $285.75. Buyers look set to stay in control over this stretch.
Expect CI to range from $302.11 to $513.05 through 2029. The $382.26 average target implies a +34% move from current prices. That is up +11% on the projected 2028 average. Momentum favours further upside here.
The CI price prediction for 2030 points to an average of $441.04 (low $343.98, high $602.41) — a potential gain of +54% on today's $285.75. Buyers look set to stay in control over this stretch.
In 2031, CI is projected to trade between $398.45 and $717.24, averaging $517.05 — a potential gain of +81% from today's $285.75. That is up +17% on the projected 2030 average. Momentum favours further upside here.
The Cigna Group's 2032 outlook centres on $577.49, within a $440.09 to $812.33 range. That is up +12% on the projected 2031 average. That marks a +102% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, CI could reach as high as $854.70, with a base case around $599.92 and support toward $452.46 — roughly +110% from $285.75. Momentum favours further upside here.
Expect CI to range from $483.81 to $933.88 through 2034. The $647.83 average target implies a +127% move from current prices. That is up +8% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The CI price prediction for 2035 points to an average of $685.51 (low $507.18, high $999.12) — a potential gain of +140% on today's $285.75. Momentum favours further upside here.
In 2040, CI is projected to trade between $745.09 and $1,603.56, averaging $1,050.20 — a potential gain of +268% from today's $285.75. That is up +53% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The Cigna Group's 2050 outlook centres on $2,104.53, within a $1,392.42 to $3,443.58 range. That is up +100% on the projected 2040 average. That marks a +636% change versus current levels. Momentum favours further upside here.
Investing $1,000 in CI today (≈ 3.499563 CI) could be worth
$7,364.92
+$6,364.92 (+636%) by 2050 · US Dollar
Based on the average projected CI price of $2,104.53 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CIwould be worth at today's price.
$1,000 invested in CI on May 27, 2025 (≈ 3.171784 CI) would be worth
$906.34
-$93.66 (-9.4%) today · 0.91× · US Dollar
Based on a CI entry price of $315.28 vs. today's $285.75.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $283.1 | $1,009.36 | +0.9% |
| 1 month ago | $282.58 | $1,011.22 | +1.1% |
| 3 months ago | $288.82 | $989.37 | -1.1% |
| 6 months ago | $277.28 | $1,030.55 | +3.1% |
| 1 year ago | $315.28 | $906.34 | -9.4% |
| All time (5.0y) ago | $257.68 | $1,108.93 | +10.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CI forecast.
Our base-case forecast reaches $570.00 around 2032.
Implied market cap at $570.00: $150.78B
The multi-year forecast shows a pronounced long-run bullish trajectory. In 2026 the average is $286.24 with a min of $258.08 and a max of $370.93, and ROI of 0 with neutral sentiment. The path extends through 2027–2050, with increasingly higher averages and ROIs: 2027 avg $330.87; 2027 min $270.23, max $424.12; ROI 15.6; sentiment NEUTRAL.
2028 avg $350.02; ROI 22.3; 2029 avg $387.27; ROI 35.3. 2030 min $352.63, avg $452.21, max $617.81; ROI 58; sentiment BULLISH. 2031 min $408.04, avg $529.58, max $734.76; ROI 85. 2032 min $448.80, avg $589.00, max $828.68; ROI 105.8.
2033 min $466.03, avg $618.00, max $880.60; ROI 115.9. 2034 min $497.54, avg $666.29, max $960.65; ROI 132.8. 2035 min $519.68, avg $702.49, max $1,024.01; ROI 145.4. The forecast then shows continued upside into 2040 with min $772.01, avg $1,088.25, max $1,661.85; ROI 280.2; sentiment BULLISH.
By 2050, min $1,448.00, avg $2,188.72, max $3,581.62; ROI 664.6; sentiment BULLISH. These figures indicate a sustained bullish bias over the long horizon, though they are estimates and not guarantees.
Tap a question to reveal the answer.
2030 min $352.63, avg $452.21, max $617.81; ROI 58; sentiment BULLISH.
The forecast shows a long-term bullish trajectory with rising averages through 2050 and a 2030–2050 path that includes higher ROIs (e.g., 58 in 2030, 280.2 in 2040, 664.6 in 2050). The 2026 forecast is neutral with an average of $286.24 and ROI 0. These are estimates, not guarantees.
The 2035 max is $1,024.01, which is just above $1,000.
Current price is $286.24 and market cap is $75.72B.
Sentiment is BULLISH. RSI14 is 50; SMA50 is $277.21; SMA200 is $282.16. Support is $268.63 and resistance is $300.71. The 30-day range runs from $259.34 to $315.94.
The Cigna Group Community Discussion
0Share your The Cigna Group price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.